Related Experiment Videos
Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis
Abstract:
A new abnormal plasminogen, Frankfurt I, has been identified in the plasma of a 42 year-old male patient who has recurrent deep vein thrombosis. Clinical laboratory data showed normal hemostasis test results. Since plasma plasmin generation rates gave low values, the fibrinolytic system was analyzed for a possible fibrinolytic system defect. Functional and antigen plasminogen concentrations both in the plasma and with the isolated, purified plasminogen showed that only 49% of the antigen concentration had potential functional active sites. Also, a reduced antigen concentration was found in both the propositus, and his mother (46% active sites). Sodium dodecyl sulfate polyacrylamide gel electrophoresis of the purified Frankfurt I plasminogen showed a normal native Glu-plasminogen band. Crossed-immunoelectrophoresis revealed a peak with normal size and shape, but displaced with respect to normal Glu-plasminogen toward the anode, i.e., was, as a whole, more negatively charged. Isoelectric focusing followed by zymography on a agarose-fibrin plate proved this observation, but did not indicate a separation of the normal from the abnormal plasminogen molecular species, also, fewer bands were found in the abnormal plasminogen isozyme pattern. Kinetic studies of Frankfurt I Glu-plasminogen and plasmin led to the conclusion that most of the functional abnormality is related to absence of active sites in half of the molecules. The plasmin generated was very unstable in the absence of stabilizing ligands and/or substrates. After reduction, the plasmin was completely converted to the typical two plasmin chains, A and B.
Insights
A novel abnormal plasminogen, Frankfurt I, was found in a patient with deep vein thrombosis, despite normal clotting tests. This defect involves reduced functional activity due to missing active sites in plasminogen molecules.
Area of Science:
- Hematology
- Molecular Biology
- Biochemistry
Background:
- Recurrent deep vein thrombosis (DVT) can stem from defects in the fibrinolytic system.
- Plasminogen is a key protein in fibrinolysis, responsible for generating plasmin to break down blood clots.
Observation:
- A patient with recurrent DVT presented with normal hemostasis but low plasma plasmin generation rates.
- Analysis revealed that approximately half of the plasminogen molecules in the patient (and his mother) lacked functional active sites.
Findings:
- The abnormal plasminogen, termed Frankfurt I, exhibited normal size and shape but had increased negative charge compared to normal plasminogen.
- Electrophoretic and isoelectric focusing studies indicated a functional abnormality related to the absence of active sites in 50% of the plasminogen molecules.
- The generated plasmin was unstable without stabilizing factors.
Implications:
- This discovery identifies a new molecular defect in plasminogen associated with thrombotic events.
- Understanding this abnormality provides insights into the critical role of functional plasminogen activity in preventing thrombosis.
- Further research may explore therapeutic strategies targeting fibrinolytic deficiencies.